These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26191791)

  • 1. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
    Tooulia KK; Theodosis-Nobelos P; Rekka EA
    Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
    Chrysselis MC; Rekka EA; Kourounakis PN
    J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
    Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
    J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide releasing morpholine derivatives as hypolipidemic and antioxidant agents.
    Chrysselis MC; Rekka EA; Siskou IC; Kourounakis PN
    J Med Chem; 2002 Nov; 45(24):5406-9. PubMed ID: 12431068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity.
    Katselou MG; Matralis AN; Kourounakis AP
    Eur J Med Chem; 2017 Sep; 138():748-760. PubMed ID: 28728107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of more potent squalene synthase inhibitors with multiple activities.
    Kourounakis AP; Matralis AN; Nikitakis A
    Bioorg Med Chem; 2010 Nov; 18(21):7402-12. PubMed ID: 20888243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents.
    Sashidhara KV; Palnati GR; Dodda RP; Sonkar R; Khanna AK; Bhatia G
    Eur J Med Chem; 2012 Nov; 57():302-10. PubMed ID: 23078966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
    Sashidhara KV; Dodda RP; Sonkar R; Palnati GR; Bhatia G
    Eur J Med Chem; 2014 Jun; 81():499-509. PubMed ID: 24871900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antioxidant, and cytotoxic activities of N-azole substituted thiomorpholine derivatives.
    Reddy PR; Reddy GM; Padmaja A; Padmavathi V; Kondaiah P; Krishna NS
    Arch Pharm (Weinheim); 2014 Mar; 347(3):221-8. PubMed ID: 24395622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzoxazine and benzothiazine derivatives as multifunctional antihyperlipidemic agents.
    Matralis AN; Katselou MG; Nikitakis A; Kourounakis AP
    J Med Chem; 2011 Aug; 54(15):5583-91. PubMed ID: 21702499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
    Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate.
    Shattat G; Al-Qirim T; Sweidan K; Shahwan M; El-Huneidi W; Al-Hiari Y
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):751-5. PubMed ID: 20590406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
    Matralis AN; Kourounakis AP
    J Med Chem; 2014 Mar; 57(6):2568-81. PubMed ID: 24568631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.
    Ladopoulou EM; Matralis AN; Nikitakis A; Kourounakis AP
    Bioorg Med Chem; 2015 Nov; 23(21):7015-23. PubMed ID: 26433631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesis.
    Tavridou A; Kaklamanis L; Megaritis G; Kourounakis AP; Papalois A; Roukounas D; Rekka EA; Kourounakis PN; Charalambous A; Manolopoulos VG
    Eur J Pharmacol; 2006 Mar; 535(1-3):34-42. PubMed ID: 16545796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory and Hypolipidemic Effect of Novel Conjugates with Trolox and Other Antioxidant Acids.
    Theodosis-Nobelos P; Kourounakis PN; Rekka EA
    Med Chem; 2017; 13(3):214-225. PubMed ID: 27823562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism.
    Hiyoshi H; Yanagimachi M; Ito M; Saeki T; Yoshida I; Okada T; Ikuta H; Shinmyo D; Tanaka K; Kurusu N; Tanaka H
    Eur J Pharmacol; 2001 Nov; 431(3):345-52. PubMed ID: 11730728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel tricyclic compounds as squalene synthase inhibitors.
    Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A
    Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
    Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP2300 compounds: focusing on the antiatherosclerotic properties of squalene synthase inhibitors.
    Tavridou A; Manolopoulos VG
    Curr Pharm Des; 2009; 15(27):3167-78. PubMed ID: 19754389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.